The Theme Day on AAV Vectors organised by SFTCG will take place at Institut du Cerveau (Paris) on 17 March 2026. The day will focus on the manufacturing and therapeutic use of AAV gene-therapy vectors, bringing together researchers and industry to discuss the latest findings and developments. It offers a platform for knowledge-sharing, poster/oral presentations and fostering collaborations in the field of AAV gene therapy. In the evening, a roundtable discussion will also be held with patient associations, providing an opportunity for dialogue on expectations, challenges and future perspectives in AAV-based therapies.
